There are currently no authorised vaccinations for Respiratory Syncytial Virus (RSV) anywhere in the world.
Continue readingCategory: Pharma
Weekly Snapshot of Top Trends in the HLS Industry
These are the weekly disruptions seen in the healthcare industry from last week.
Continue readingGilead wins FDA’s priority review for its breast cancer medicine
Gilead’s Trodelvy, a breast cancer medicine, makes a comeback as it wins FDA priority review on the application for highly
Continue readingWith EMA’s guidance, Freya Pharma’s pill to enter phase III trials
Lybrido, an oral tablet from Freya Pharma Solutions, will enter Phase III studies to treat female sexual interest/arousal issue (FSIAD)
Continue readingWeekly Snapshot of Top Trends in the HLS Industry
These are the weekly disruptions seen in the healthcare industry from last week.
Continue readingMerck to double down pharma facility in Singapore
While other pharma companies are entering Singapore, owing to its far-sightedness, Merck is expanding by establishing a new manufacturing facility.
Continue readingAmylyx’s ALS drug receives the long overdue approval by FDA
Amylyx’s amyotrophic lateral sclerosis (ALS) drug, marketed as Relyvrio, has been approved by the FDA for the treatment of ALS
Continue readingWeekly Snapshot of Top Trends in the HLS Industry
These are the weekly disruptions seen in the healthcare industry from last week.
Continue readingBora Pharmaceuticals teams up with TaiRX for drug development
Bora Pharmaceuticals joins hands with TaiRX, a Taiwan-based company focused on drug development, to formulate CVM-1118, an anticancer drug.
Continue readingIpsen scales in Ireland with $50M investment in its facilities
As Ireland proceeds ahead to become the hub of pharma manufacturing projects, Ipsen becomes the latest company to hop on
Continue reading
English